Human monoclonal antibody firm collaborating with Big Pharma

Immunome, which has developed a way to clone monoclonal human antibodies that can be used to help develop more effective cancer drugs and with potential applications for rare diseases, has signed its first research and development partnership with a..

Original Article: Human monoclonal antibody firm collaborating with Big Pharma

 Channels 91 Associated Channels

• Monoclonal antibody therapy

• CD30 Antibodies

  CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. This receptor is expressed by activated, but not by resting, T and B cells. It...

• Monoclonal antibodies

• T lymphocyte receptor CD3

  CD3 is a T lymphocyte receptor involved in normal cell signaling. Antagonists of CD3 are thought to work by blocking the function of T effector cells that attack the body’s tissues and cause aut...

• Antibody Drug Conjugates ADC

  The humanized anti-Her2 monoclonal antibody Herceptin (trastuzumab) has become the mainstay in the treatment of Her2-positive breast cancer. Combining trastuzumab with the potent cytotoxic DM1 via a s...

• Monoclonal antibodies mAbs

• Antibody classes

  An antibody, also known as an immunoglobulin, is a large Y-shaped protein used by the immune system to identify and neutralize foreign objects such as bacteria and viruses. The antibody recognizes a...

• Monoclonal Gammopathy of Undetermined Significance MGUS

• CD20 Antibodies

  The chimeric anti-CD20 antibody rituximab (Rituxan & MabThera) from Biogen Idec and Genentech/Roche is one of the world’s commercially most successful antibodies (2007 sales of over US$ 5 bl...

• Antiphospholipid Antibody Syndrome

Associated Content for this Article

• View Related Companies
• View Related Events
• View Related Clinical Trials
• View Related PubMed Articles
• View Related Medications

Latest Biotechnology, Pharmaceutical and Healthcare News

Searches Linking to this Page

None